India Pre-Market Regulatory Roundup — October 29, 2026
The 50 overnight Indian filings (28-29 Oct 2026) are dominated by Q2 FY27 results and governance disclosures, with a clear bifurcation between strong earnings growth at several mid-caps and deep financial distress at TruCap Finance. Headline growth is robust: Acme Solar reported consolidated revenue up 67.5% YoY and PAT up 133.5%, Creative Newtech saw consolidated total income up 14.4% and PAT up 36.9%, and Aarti Pharmalabs posted standalone revenue up 46.8% and PAT up 179.8% YoY. Margin quality is mixed, however: Acme's EBITDA margin compressed to 86.7% from 88.8%, Fabtech's Q2 net profit fell about 46.5% YoY on exceptional items, and Sasken's employee costs rose faster than revenue on a sequential basis. Sequential softness is visible at several names, including Aarti (PAT down 7.8% QoQ), Sasken (revenue down 5.4% QoQ on a 42% fall in Product Solutions), and Jindal Stainless (volume guidance cut to 4%-6% from 7%-9%). Balance-sheet and governance stress is concentrated in TruCap Finance (breached security cover, defaults, going-concern material uncertainty, Rs 58 Cr fundraise proposed) and in auditor churn at Raymond Realty. Several filings are procedural (board-meeting intimations, call-recording notices, trading-window closures) and carry little standalone signal.